Secondary Navigation Menu

WSF OpenID Connect Login

Brand Navigation Banner

Alt tag

One move can change

the outcome1

For your patients with CKD associated
with T2D, intervene now to deliver
dual cardiorenal risk reduction

Finerenone (Firialta®) is indicated for treatment of
Chronic Kidney Disease (stage 3 and 4) with albuminuria
associated with type 2 diabetes (T2D)1

CKD=chronic kidney disease; T2D=type 2 diabetes.

References: 1. Kerendia European Summary of Product Characteristics (SmPC); February 2023